Update on anti-NMDA receptor encephalitis

Brain and Nerve

Volumn 62, Issue 4, 2010, Pages 331-338

  Iizuka, Takahiro ^a   Sakai, Fumihiko ^b   Mochizuki, Hideki ^a  

^a KITASATO UNIVERSITY SCHOOL OF MEDICINE   (Japan)

^b International Headache Center   (Japan)

Author keywords

Dyskinesias; Hypoventilation; N methyl D aspartic acid receptor (NMDA) receptor; Paraneoplastic limbic encephalitis; Psychosis

Indexed keywords

AMINO ACID; DOPAMINE; DOPAMINE RECEPTOR; GLUTAMIC ACID; N METHYL DEXTRO ASPARTIC ACID RECEPTOR; N METHYL DEXTRO ASPARTIC ACID RECEPTOR ANTIBODY; RECEPTOR ANTIBODY; UNCLASSIFIED DRUG;

AMINO TERMINAL SEQUENCE; AUTOPSY; CANCER SURGERY; CATATONIA; COMPLEMENT ACTIVATION; DOPAMINERGIC NERVE CELL; DYSKINESIA; ENCEPHALITIS; HUMAN; HUMAN CELL CULTURE; HYPOVENTILATION; IMMUNOPATHOLOGY; IMMUNOTHERAPY; LAPAROTOMY; MENTAL DISEASE; MOTOR DYSFUNCTION; N METHYL DEXTRO ASPARTIC ACID RECEPTOR ANTIBODY ENCEPHALITIS; NEUROTRANSMITTER RELEASE; NONHUMAN; OVARY TERATOMA; PROTEIN DOMAIN; PROTEIN EXPRESSION; PROTEIN LOCALIZATION; REVIEW; SEIZURE; SYMPTOMATOLOGY;

ANIMALS; AUTOANTIBODIES; DYSKINESIAS; FEMALE; HUMANS; HYPOVENTILATION; IMMUNOTHERAPY; LIMBIC ENCEPHALITIS; MALE; NEUROSURGICAL PROCEDURES; NEUROTRANSMITTER AGENTS; NUCLEOPROTEINS; PSYCHOTIC DISORDERS; RECEPTORS, N-METHYL-D-ASPARTATE;

EID: 77951555708     PISSN: 18816096     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Review

References (36)

1. Dalmau J, Tüzün E, Wu HY, Masjuan J, Rossi JE, et al: Paraneoplastic anti-N-methyl-D-aspartate receptor encephalitis associated with ovarian teratoma. Ann Neurol 61: 25-36, 2007 (Pubitemid 46214241)
2. Tüzün E, Dalmau J: Limbic encephalitis and variants: classification, diagnosis and treatment. Neurologist 13: 261-271, 2007 (Pubitemid 47396312)
3. Graus F, Saiz A, Lai M, Bruna J, López F, et al: Neuronal surface antigen antibodies in limbic encephalitis: clinical-immunologic associations. Neurology 71: 930-936, 2008
4. Lai M, Hughes EG, Peng X, Zhou L, Gleichman AJ, et al: AMPA receptor antibodies in limbic encephalitis alter synaptic receptor location. Ann Neurol 65: 424-434, 2009
5. Lancaster E, Lai M, Peng X, Hughes E, Constantinescu R, et al: Antibodies to the GABA (B) receptor in limbic encephalitis with seizures: case series and characterisation of the antigen. Lancet Neurol 9: 67-76, 2009
6. Brain Nerve 60: 1047-1060, 2008
7. Nokura K, Yamamoto H, Okawara Y, Koga H, Osawa H, et al: Reversible limbic encephalitis caused by ovarian teratoma. Acta Neurol Scand 95: 367-373, 1997 (Pubitemid 27287937)
8. Okamura H, Oomori N, Uchitomi Y: An acutely confused 15-year-old girl. Lancet 350: 488, 1997 (Pubitemid 27343305)
9. Vitaliani R, Mason W, Ances B, Zwerdling T, Jiang Z, et al: Paraneoplastic encephalitis, psychiatric symptoms, and hypoventilation in ovarian teratoma. Ann Neurol 58:594-604, 2005 (Pubitemid 41377223)
10. Kawaguchi K, Kishida S, Okeda R, Funata N, Koike M: Encephalomyeloneuritis with mediastinal germ cell tumor. A paraneoplastic condition? Acta Pathol Jpn 38: 351-359, 1988
11. Iizuka T, Sakai F, Ide T, Monzen T, Yoshii S, et al: Anti-NMDA receptor encephalitis in Japan: long-term outcome without tumor removal. Neurology 70: 504-511, 2008 (Pubitemid 351653374)
12. Ishiura H, Matsuda S, Higashihara M, Hasegawa M, Hida A, et al: Response of anti-NMDA receptor encephalitis without tumor to immunotherapy including rituximab. Neurology 71: 1921-1923, 2008
13. Novillo-López ME, Rossi JE, Dalmau J, Masjuan J: Treatment-responsive subacute limbic encephalitis and NMDA receptor antibodies in a man. Neurology 70: 728-729, 2008
14. Wilder-Smith EP, Ng ES: The writing on the wall. Lancet 372: 344, 2008
15. Eker A, Saka E, Dalmau J, Kurne A, Bilen C, et al: Testicular teratoma and anti-N-methyl-D-aspartate receptor-associated encephalitis. J Neurol Neurosurg Psychiatry 79: 1082-1083, 2008
16. Kamei S, Kuzuhara S, Ishihara M, Morita A, Taira N, et al: Nationwide survey of acute juvenile female non-herpetic encephalitis in Japan: relationship to anti-N-methyl-d-aspartate receptor encephalitis. Intern Med 48: 673-679, 2009
17. Dalmau J, Gleichman AJ, Hughes EG, Rossi JE, Peng X, et al: Anti-NMDA-receptor encephalitis: case series and analysis of the effects of antibodies. Lancet Neurol 7: 1091-1098, 2008
18. Tower J, Malkin M, Rathke S, Novoa-Takara L, Ho Khang-cheng: Fatal anti-NMDA receptor paraneoplastic encephalitis due to microscopic ovarian teratoma. Neurology 72(Suppl 3): A26, 2009
19. Florance NR, Davis RL, Lam C, Szperka C, Zhou L, et al: Anti-N-methyl-D-aspartate receptor (NMDAR) encephalitis in children and adolescents. Ann Neurol 66: 11-18, 2009
20. Niehusmann P, Dalmau J, Rudlowski C, Vincent A, Elger CE, et al: Diagnostic value of N-methyl-D- aspartate receptor antibodies in women with new- onset epilepsy. Arch Neurol 66: 458-464, 2009
21. Lee A, Glick DB, Dinwiddie SH: Electroconvulsive therapy in a pediatric patient with malignant catatonia and paraneoplastic limbic encephalitis. J ECT 22: 267-270, 2006 (Pubitemid 44901119)
22. Kleinig TJ, Thompson PD, Matar W, Duggins A, Kimber TE, et al: The distinctive movement disorder of ovarian teratoma-associated encephalitis. Mov Disord 23: 1256-1261, 2008
23. Seki M, Suzuki S, Iizuka T, Shimizu T, Nihei Y, et al: Neurological response to early removal of ovarian teratoma in anti-NMDAR encephalitis. J Neurol Neurosurg Psychiatry 79: 324-326, 2008 (Pubitemid 351303394)
24. Iizuka T, Yoshii S, Ide T, Hamada J, Kan S, et al: Reversible brain atrophy in anti-NMDA receptor encephalitis: a long-term observational study. Neurology 72(Suppl 3): A27-A28, 2009
25. Stone JM, Morrison PD, Pilowsky LS: Glutamate and dopamine dysregulation in schizophrenia - a synthesis and selective review. J Psychopharmacol 21: 440-452, 2007
26. Gardoni F, Picconi B, Ghiglieri V, Polli F, Bagetta V et al: A critical interaction between NR2B and MAGUK in L-DOPA induced dyskinesia. J Neurosci 26: 2914-2922, 2006
27. Konitsiotis S, Tsironis C, Kiortsis DN, Evangelou A: Effects of N-methyl-D-aspartate receptor antagonism on neuroleptic-induced orofacial dyskinesias. Psychopharmacology (Berl) 185: 369-377, 2006
28. Nash JE, Ravenscroft P, McGuire S, Crossman AR, Menniti FS, et al: The NR2B-selective NMDA receptor antagonist CP-101,606 exacerbates L-DOPA- induced dyskinesia and provides mild potentiation of anti-parkinsonian effects of L-DOPA in the MPTP- lesioned marmoset model of Parkinson's disease. Exp Neurol 188: 471-479, 2004 (Pubitemid 38891607)
29. Sansing LH, Tüzün E, Ko MW, Baccon J, Lynch DR, et al: A patient with encephalitis associated with NMDA receptor antibodies. Nat Clin Pract Neurol 3: 291-296, 2007 (Pubitemid 46745476)
30. Tüzün E, Zhou L, Baehring JM, Bannykh S, Rosenfeld MR, et al: Evidence for antibody-mediated pathogenesis in anti-NMDAR encephalitis associated with ovarian teratoma. Acta Neuropathol August 14 2009 [Epub ahead of print]
31. Ishiura H, Matsuda S, Higashihara M, Hasegawa M, Hida A, et al: Response of anti-NMDA receptor encephalitis without tumor to immunotherapy including rituximab. Neurology 71: 1921-1923, 2008